Chemotactic Cytokines

Focuses on the potential use of a family of chemotactic cytokines, discovered in 1987, for treating inflammatory diseases. Most of the 17 papers and 34 abstracts are concerned with the regulation of the peptides at the molecular and cellular level, but others report on recent evidence that some of them may be implicated in the pathogenesis of arthritis, psoriasis, atherosclerosis, and other diseases.